Does RAVULIZUMAB-CWVZ Cause Hypersomnia? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Hypersomnia have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.3% of all adverse event reports for RAVULIZUMAB-CWVZ.
34
Reports of Hypersomnia with RAVULIZUMAB-CWVZ
0.3%
of all RAVULIZUMAB-CWVZ reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hypersomnia From RAVULIZUMAB-CWVZ?
Of the 34 reports, 2 (5.9%) required hospitalization.
Is Hypersomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Hypersomnia?
PIMAVANSERIN (602)
ADALIMUMAB (467)
LENALIDOMIDE (401)
QUETIAPINE (394)
PREGABALIN (347)
TREPROSTINIL (317)
RISPERIDONE (302)
ARIPIPRAZOLE (286)
DULOXETINE (285)
OXYCODONE (280)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Hypersomnia Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST